The National Healthcare Security Administration said on Monday that 557 drugs have passed the preliminary review for ...

Indian companies filed 184 Type II DMFs with the US FDA in Q1 2026 against China's 149, reinforcing the country's leadership ...

When life sciences startups think about patent strategy, the natural instinct is to focus on the core science — the novel compound, the ...

Health advocacy groups have urged the government to reject TRIPS-plus provisions in Thailand's free trade negotiations with the European Union (EU), warning they could delay access to generic ...

On June 16, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule, “Medicare Drug Price Negotiation Program and ...

In corporate management, nothing is more daunting than uncertainty, not even loss itself. If the scale of a loss can be predicted, countermeasures can ...

While multinational pharmaceutical companies use India to test out their new medicines, India’s researchers rarely lead the ...

TEMPO.CO, Jakarta - The Ministry of Health will bring in doctors from Belarus to train medical personnel in Indonesia. Both ...

Divis Laboratories benefits from strong CDMO demand but faces high valuations, prompting a hold recommendation for investors.

As drug costs and spending continue to rise, the demand for solutions opens the door to closer collaboration between payers ...

Mankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This ...

Kriya Therapeutics, Inc. ("Kriya"), a biotechnology company developing durable medicines for chronic diseases, today announced it has been selected by the U.S. Food and Drug Administration (FDA) to ...